Inhibiting GLUTtony in cancer
- PMID: 35303439
- DOI: 10.1016/j.chembiol.2022.03.004
Inhibiting GLUTtony in cancer
Abstract
In this issue of Cell Chemical Biology, Olszewski et al. (2022) address the challenge of developing small molecules to inhibit glucose uptake in cancer. They characterize a novel pan-GLUT inhibitor that suppresses tumor growth and uncover how cancer cells can adapt to glucose restriction.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests M.G.V.H. is a scientific advisor for Agios Pharmaceuticals, iTeos Therapeutics, Faeth Therapeutics, Sage Therapeutics, and Auron Therapeutics.
Comment on
-
Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors.Cell Chem Biol. 2022 Mar 17;29(3):423-435.e10. doi: 10.1016/j.chembiol.2021.10.007. Epub 2021 Oct 28. Cell Chem Biol. 2022. PMID: 34715056
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
